Protagonist Therapeutics Inc (PTGX)

Revenue

$213.48M

Quarterly · Period ending: · USD

PTGX logo

PTGX Revenue

Latest reported$213.48M
PTGX Quarterly Revenue ($0.00 → $213.48M)
High-resolution chart · PNG

PTGX revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Protagonist Therapeutics Inc Revenue — Quarterly (USD)
Period endingRevenue (USD)
213,475,000
56,368,000
7,437,000
4,712,000
5,546,000
28,321,000
170,638,000
4,675,000
4,167,000
254,953,000
60,000,000
0
0
0
0
0
859,000
25,722,000
8,617,000
10,286,000
2,265,000
6,189,000
5,650,000
13,114,000
6,217,000
3,647,000
2,719,000
4,141,000
-8,189,000
1,560,000
2,353,000
6,117,000
11,674,000
10,781,000
11,282,000
8,781,000
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.